Neuroscience Unit, KEMRI-Wellcome Trust, Center for Geographic Medicine Research Coast, Kilifi, Kenya; Complex Trait Genetics Department, Center for Neurogenomics and Cognitive Research, Vrije Universiteit Amsterdam, Amsterdam, the Netherlands.
The Broad Institute of MIT and Harvard, Cambridge, MA, USA.
Neuron. 2023 Sep 20;111(18):2800-2810.e5. doi: 10.1016/j.neuron.2023.06.010. Epub 2023 Jul 17.
Genetic association studies have made significant contributions to our understanding of the etiology of neurodevelopmental disorders (NDDs). However, these studies rarely focused on the African continent. The NeuroDev Project aims to address this diversity gap through detailed phenotypic and genetic characterization of children with NDDs from Kenya and South Africa. We present results from NeuroDev's first year of data collection, including phenotype data from 206 cases and clinical genetic analyses of 99 parent-child trios. Most cases met criteria for global developmental delay/intellectual disability (GDD/ID, 80.3%). Approximately half of the children with GDD/ID also met criteria for autism. Analysis of exome-sequencing data identified a pathogenic or likely pathogenic variant in 13 (17%) of the 75 cases from South Africa and 9 (38%) of the 24 cases from Kenya. Data from the trio pilot are publicly available, and the NeuroDev Project will continue to develop resources for the global genetics community.
遗传关联研究为我们理解神经发育障碍 (NDD) 的病因做出了重大贡献。然而,这些研究很少关注非洲大陆。NeuroDev 项目旨在通过对肯尼亚和南非的 NDD 儿童进行详细的表型和遗传特征分析来解决这一多样性差距。我们展示了 NeuroDev 第一年数据收集的结果,包括 206 例病例的表型数据和 99 个亲子三对的临床遗传分析。大多数病例符合全面发育迟缓/智力残疾 (GDD/ID,80.3%)的标准。大约一半的 GDD/ID 儿童也符合自闭症的标准。对外显子组测序数据的分析在来自南非的 75 例病例中的 13 例 (17%)和来自肯尼亚的 24 例病例中的 9 例 (38%)中发现了致病性或可能致病性的变异。三对试点项目的数据是公开的,NeuroDev 项目将继续为全球遗传学社区开发资源。